PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 15276086-1 2004 P-glycoprotein (PGP) substrates with high membrane permeability, such as propranolol and verapamil, are considered to be essentially "transparent" to PGP since the transporter does not significantly limit their absorption or elimination. Propranolol 73-84 ATP binding cassette subfamily B member 1 Homo sapiens 0-14 15276086-1 2004 P-glycoprotein (PGP) substrates with high membrane permeability, such as propranolol and verapamil, are considered to be essentially "transparent" to PGP since the transporter does not significantly limit their absorption or elimination. Propranolol 73-84 ATP binding cassette subfamily B member 1 Homo sapiens 16-19 15276086-7 2004 The induction of PGP by propranolol and verapamil was rapid with significant increases occurring within 3h with maximal stimulation after 6h exposure. Propranolol 24-35 ATP binding cassette subfamily B member 1 Homo sapiens 17-20 15276086-9 2004 In conclusion, verapamil and propranolol, whose trans-epithelial permeability are unaffected by PGP, appear to be effective inducers of PGP expression in gut epithelial cells in vitro. Propranolol 29-40 ATP binding cassette subfamily B member 1 Homo sapiens 136-139 14744938-8 2004 Next, erythromycin and propranolol were explored as positive and negative control substrates for Pgp/CYP3A interactions, respectively. Propranolol 23-34 ATP binding cassette subfamily B member 1 Homo sapiens 97-100 19380024-4 2009 The mRNA expression of the ABCB1 gene (previously MDR1) in human colon carcinoma HT-29 cell line was measured after treatment with an adrenergic receptor agonist (adrenaline) and various antagonists (propranolol, prazosin, and yohimbine). Propranolol 200-211 ATP binding cassette subfamily B member 1 Homo sapiens 27-32 15023456-2 2004 Propranolol is a poorly soluble drug and known substrate of the P-glycoprotein (P-gp) efflux transporter. Propranolol 0-11 ATP binding cassette subfamily B member 1 Homo sapiens 64-78 15023456-2 2004 Propranolol is a poorly soluble drug and known substrate of the P-glycoprotein (P-gp) efflux transporter. Propranolol 0-11 ATP binding cassette subfamily B member 1 Homo sapiens 80-84 11576779-7 2001 The most hydrophobic beta-ligand, propranolol, a known Pgp substrate, gave the largest increase in Rh123 accumulation in this therapeutic class. Propranolol 34-45 ATP binding cassette subfamily B member 1 Homo sapiens 55-58 19672719-7 2009 Also, the absorption of various drugs such as propranolol through P-glycoprotein (P-gp) efflux transporter is low and erratic. Propranolol 46-57 ATP binding cassette subfamily B member 1 Homo sapiens 66-80 19672719-7 2009 Also, the absorption of various drugs such as propranolol through P-glycoprotein (P-gp) efflux transporter is low and erratic. Propranolol 46-57 ATP binding cassette subfamily B member 1 Homo sapiens 82-86 16671962-4 2006 Therefore, we investigated the P-glycoprotein-mediated transport of propranolol, metoprolol, bisoprolol, carvedilol and sotalol in P-glycoprotein-expressing Caco-2 monolayers and inhibition of P-glycoprotein-mediated digoxin transport by the beta-adrenoceptor antagonists. Propranolol 68-79 ATP binding cassette subfamily B member 1 Homo sapiens 31-45 16671962-6 2006 Moreover, propranolol and carvedilol inhibited P-glycoprotein-mediated digoxin transport with IC(50) values of 24.8 and 0.16 microm, respectively, whereas metoprolol and sotalol had no effect. Propranolol 10-21 ATP binding cassette subfamily B member 1 Homo sapiens 47-61 16671962-9 2006 In addition, the beta-adrenoceptor antagonists propranolol and carvedilol significantly inhibit P-glycoprotein function thereby possibly contributing to drug interactions in humans (e.g. digoxin-carvedilol and cyclosporine-carvedilol). Propranolol 47-58 ATP binding cassette subfamily B member 1 Homo sapiens 96-110